These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 25562317)

  • 21. The impact of heptavalent pneumococcal conjugate vaccine on the incidence of childhood community-acquired pneumonia and bacteriologically confirmed pneumococcal pneumonia in Japan.
    Naito S; Tanaka J; Nagashima K; Chang B; Hishiki H; Takahashi Y; Oikawa J; Nagasawa K; Shimojo N; Ishiwada N
    Epidemiol Infect; 2016 Feb; 144(3):494-506. PubMed ID: 26122538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe bronchiolitis and respiratory syncytial virus among young children in Hawaii.
    Yorita KL; Holman RC; Steiner CA; Effler PV; Miyamura J; Forbes S; Anderson LJ; Balaraman V
    Pediatr Infect Dis J; 2007 Dec; 26(12):1081-8. PubMed ID: 18043442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory syncytial virus season and hospitalizations in the Alaskan Yukon-Kuskokwim Delta.
    Singleton RJ; Bruden D; Bulkow LR
    Pediatr Infect Dis J; 2007 Nov; 26(11 Suppl):S46-50. PubMed ID: 18090200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nasopharyngeal Pneumococcal Carriage During Childhood Community-Acquired Alveolar Pneumonia: Relationship Between Specific Serotypes and Coinfecting Viruses.
    Greenberg D; Givon-Lavi N; Faingelernt Y; Ben-Shimol S; Avni YS; Bar-Ziv J; Dagan R
    J Infect Dis; 2017 Apr; 215(7):1111-1116. PubMed ID: 28011920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15.
    Arriola CS; Kim L; Langley G; Anderson EJ; Openo K; Martin AM; Lynfield R; Bye E; Como-Sabetti K; Reingold A; Chai S; Daily P; Thomas A; Crawford C; Reed C; Garg S; Chaves SS
    J Pediatric Infect Dis Soc; 2020 Nov; 9(5):587-595. PubMed ID: 31868913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory syncytial virus circulation in seven countries with Global Disease Detection Regional Centers.
    Haynes AK; Manangan AP; Iwane MK; Sturm-Ramirez K; Homaira N; Brooks WA; Luby S; Rahman M; Klena JD; Zhang Y; Yu H; Zhan F; Dueger E; Mansour AM; Azazzy N; McCracken JP; Bryan JP; Lopez MR; Burton DC; Bigogo G; Breiman RF; Feikin DR; Njenga K; Montgomery J; Cohen AL; Moyes J; Pretorius M; Cohen C; Venter M; Chittaganpitch M; Thamthitiwat S; Sawatwong P; Baggett HC; Luber G; Gerber SI
    J Infect Dis; 2013 Dec; 208 Suppl 3():S246-54. PubMed ID: 24265484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-cause pneumonia hospitalizations in children <2 years old in sweden, 1998 to 2012: impact of pneumococcal conjugate vaccine introduction.
    Berglund A; Ekelund M; Fletcher MA; Nyman L
    PLoS One; 2014; 9(11):e112211. PubMed ID: 25379659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospitalizations for acute lower respiratory tract infection due to respiratory syncytial virus in Thailand, 2008-2011.
    Naorat S; Chittaganpitch M; Thamthitiwat S; Henchaichon S; Sawatwong P; Srisaengchai P; Lu Y; Chuananon S; Amornintapichet T; Chantra S; Erdman DD; Maloney SA; Akarasewi P; Baggett HC
    J Infect Dis; 2013 Dec; 208 Suppl 3():S238-45. PubMed ID: 24265483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011.
    Moyes J; Cohen C; Pretorius M; Groome M; von Gottberg A; Wolter N; Walaza S; Haffejee S; Chhagan M; Naby F; Cohen AL; Tempia S; Kahn K; Dawood H; Venter M; Madhi SA;
    J Infect Dis; 2013 Dec; 208 Suppl 3():S217-26. PubMed ID: 24265481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.
    Greenberg D; Givon-Lavi N; Ben-Shimol S; Ziv JB; Dagan R
    Vaccine; 2015 Aug; 33(36):4623-9. PubMed ID: 26116251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumococcal conjugate vaccines decrease community-acquired alveolar pneumonia with and without pleural effusion in children <60 months in Southern Israel, 2002-2016.
    Triadou D; Givon-Lavi N; Greenberg D; Ben-Shimol S
    Infect Dis (Lond); 2020 Mar; 52(3):186-195. PubMed ID: 31774020
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of case definitions for estimation of respiratory syncytial virus associated hospitalizations among children in a rural community of northern India.
    Saha S; Pandey BG; Choudekar A; Krishnan A; Gerber SI; Rai SK; Singh P; Chadha M; Lal RB; Broor S
    J Glob Health; 2015 Dec; 5(2):010419. PubMed ID: 26649172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002.
    Henckel E; Luthander J; Berggren E; Kapadia H; Naver L; Norman M; Bennet R; Eriksson M
    Pediatr Infect Dis J; 2004 Jan; 23(1):27-31. PubMed ID: 14743042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of respiratory syncytial virus infection and influenza with emergency admissions for respiratory disease in London: an analysis of routine surveillance data.
    Mangtani P; Hajat S; Kovats S; Wilkinson P; Armstrong B
    Clin Infect Dis; 2006 Mar; 42(5):640-6. PubMed ID: 16447109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the hospitalization burden associated with influenza and respiratory syncytial virus in New York City, 2003-2011.
    Goldstein E; Greene SK; Olson DR; Hanage WP; Lipsitch M
    Influenza Other Respir Viruses; 2015 Sep; 9(5):225-33. PubMed ID: 25980600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US.
    Zheng Z; Pitzer VE; Shapiro ED; Bont LJ; Weinberger DM
    JAMA Netw Open; 2021 Dec; 4(12):e2141779. PubMed ID: 34913973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and clinical features of respiratory syncytial virus infections in a population-based surveillance site in the Nile Delta Region.
    Rowlinson E; Dueger E; Taylor T; Mansour A; Van Beneden C; Abukela M; Zhang X; Refaey S; Bastawy H; Kandeel A
    J Infect Dis; 2013 Dec; 208 Suppl 3():S189-96. PubMed ID: 24265478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.
    Zhou H; Thompson WW; Viboud CG; Ringholz CM; Cheng PY; Steiner C; Abedi GR; Anderson LJ; Brammer L; Shay DK
    Clin Infect Dis; 2012 May; 54(10):1427-36. PubMed ID: 22495079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospitalizations associated with influenza and respiratory syncytial virus among patients attending a network of private hospitals in South Africa, 2007-2012.
    Kyeyagalire R; Tempia S; Cohen AL; Smith AD; McAnerney JM; Dermaux-Msimang V; Cohen C
    BMC Infect Dis; 2014 Dec; 14():694. PubMed ID: 25510622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.